CINCINNATI, March 28, 2011 /PRNewswire/ — Kendle (Nasdaq:
KNDL), a leading, global full-service clinical research
organization, today announced several of its executives will speak
on key industry issues at the 20th Annual Partnerships in Clinical
Trials Conference March 30 to April 1, 2011, in Phoenix, Ariz.
Kendle experts will address the impact of pharma industry mergers
and acquisitions on outsourcing strategies as well as best
practices for patient recruitment and retention. Kendle also
will host a “Quiz our Experts” interactive Q&A session March 31
from 3:45 to 4:15 p.m. in Booth #301 on the showroom floor to
address questions and share insights with customers on key clinical
development issues.
Participating on the executive panel “Sponsors and CROs
Unplugged – Assess the Impact of M&A On Your Outsourcing
Strategy” on Thursday, March 31 at 11:45 a.m. will be Stephen
Cutler, PhD, Kendle’s current Senior Vice President and Chief
Operating Officer who will assume the role of President and Chief
Executive Officer on May 1. With more than 20 years of senior
management and operations leadership experience in the CRO and
biopharmaceutical industries, Dr. Cutler has extensive experience
in the development and delivery of successful partnerships between
CROs and their customers (for a recent interview with Dr. Cutler in
Pharmaceutical Outsourcing on how strategic partnerships
with CROs can lead to more cost-effective
clinical development efforts, please visit
http://www.kendle.com/uploads/PharmaOutsourcing0311_Cutler.pdf).
Also representing Kendle at the conference will be Jeff Zucker,
Senior Director and Global Head, Patient Recruitment on the topic
of best practices in patient recruitment; as well as a panel of
Kendle executives featuring Mr. Zuck
‘/>”/>
SOURCE
